Trending stocks: Ipca Laboratories share price down 1%

NEW DELHI: Shares of Ipca Laboratories traded 0.78 per cent down in Thursday 's trade at 10:58AM (IST). Around 6644 shares changed hands on the counter.

The counter opened at Rs 1602.0 and touched an intraday high and low of Rs 1620.7 and Rs 1578.05 , respectively, in the session so far. Shares of the company quoted a 52-week high of Rs 1780.2 and a 52-week low of Rs 599.95 .

Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 20107.67 Crore) operating in Pharmaceuticals sector.


Mumbai-based IPCA, the largest active ingredient manufacturer of the hydroxychloroquine (HCQ) in the world, has requested the US Food and Drug Administration (USFDA) and the European Medicine Agency (EMA) to issue a clarification on their recent advisory on the use of this drug and its possible side effects.

Key Financials

The company reported consolidated sales of Rs 1212.86 crore for the quarter ended 31-Dec-2019 , down -5.53 per cent from previous quarter's Rs 1283.9 crore and down 20.55 per cent from the year-ago quarter's Rs 1006.14 crore.

The net profit after tax for the latest quarter stood at Rs 197.61 crore, 24.13 per cent from the same quarter a year ago .

Shareholding pattern
As of 31-Dec-2019 , DIIs held 22.757027 per cent stake in the firm , while foreign institutional investors held 13.991459 per cent and the promoters 46.074604 per cent.

Valuation ratio

According to BSE data, the stock traded at a P/E multiple of 32.44 and a price-to-book ratio of 248.35 .A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for 'nil' growth in the business.

Ipca Laboratories Ltd. belongs to the Pharma - Indian industry.